Literature DB >> 17660447

Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis.

Mitsuhide Noshiro1, Emiko Usui, Takeshi Kawamoto, Hiroshi Kubo, Katsumi Fujimoto, Masae Furukawa, Sato Honma, Makoto Makishima, Ken-ichi Honma, Yukio Kato.   

Abstract

Cholesterol 7alpha-hydroxylase (CYP7A) and sterol 12alpha-hydroxylase (CYP8B) in bile acid biosynthesis and 3-hydroxyl-3-methylglutaryl CoA reductase (HMGCR) in cholesterol biosynthesis are the key enzymes in hepatic metabolic pathways, and their transcripts exhibit circadian expression profiles in rodent liver. The authors determined transcript levels of these enzymes and the regulatory factors for Cyp7a--including Dbp, Dec2, E4bp4, Hnf4alpha, Pparalpha, Lxralpha, Rev-erbalpha, and Rev-erbbeta--in the liver of wild-type and homozygous Clock mutant mice (Clock/Clock) and examined the effects of these transcription factors on the transcription activities of Cyp7a. The expression profile of the Cyp7a transcript in wild-type mice showed a strong circadian rhythm in both the 12L:12D light-dark cycle and constant darkness, and that in Clock/Clock also exhibited a circadian rhythm at an enhanced level with a lower amplitude, although its protein level became arrhythmic at a high level. The expression profile of Cyp8b mRNA in wild-type mice showed a shifted circadian rhythm from that of Cyp7a, becoming arrhythmic in Clock/Clock at an expression level comparable to that of wild-type mice. The expression profile of Hmgcr mRNA also lost its strong circadian rhythm in Clock/Clock , showing an expression level comparable to that of wild-type mice. The expressions of Dbp, Dec2, Rev-erbalpha, and Rev-erb beta--potent regulators for Cyp7a expression--were abolished or became arrhythmic in Clock/Clock, while other regulators for Cyp7a-Lxralpha, Hnf4alpha, Pparalpha, and E4bp4--had either less affected or enhanced expression in Clock/Clock. In luciferase reporter assays, REV-ERBalpha/beta, DBP, LXRalpha, and HNF4alpha increased the promoter activity of Cyp7a, whereas DEC2 abolished the transcription from the Cyp7a promoter: E4BP4 and PPARalpha were moderate negative regulators. Furthermore, knockdown of REV-ERBalpha/beta with siRNA suppressed Cyp7a transcript levels, and in the electrophoretic mobility shift assay, REV-ERBalpha/beta bound to the promoter of Cyp7a . These observations suggest that (1) active CLOCK is essential for the robust circadian expression of hepatic metabolic enzymes (Cyp7a, Cyp8b, and Hmgcr); (2) clock-controlled genes--DBP, DEC2, and REV-ERBalpha/beta--are direct regulators required for the robust circadian rhythm of Cyp7a; and (3) the circadian rhythm of Cyp7a is regulated by multiple transcription factors, including DBP, REV-ERBalpha/beta, LXRalpha, HNF4alpha DEC2, E4BP4, and PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17660447     DOI: 10.1177/0748730407302461

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  38 in total

1.  Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.

Authors:  Johanna H M Stroeve; Gemma Brufau; Frans Stellaard; Frank J Gonzalez; Bart Staels; Folkert Kuipers
Journal:  Lab Invest       Date:  2010-06-07       Impact factor: 5.662

2.  Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity.

Authors:  Tiangang Li; Jessica M Francl; Shannon Boehme; Adrian Ochoa; Youcai Zhang; Curtis D Klaassen; Sandra K Erickson; John Y L Chiang
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

3.  A model of the cell-autonomous mammalian circadian clock.

Authors:  Henry P Mirsky; Andrew C Liu; David K Welsh; Steve A Kay; Francis J Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-19       Impact factor: 11.205

4.  R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles.

Authors:  Liam A Finlay; Alex J Michels; Judy A Butler; Eric J Smith; Jeffrey S Monette; Régis F Moreau; Shay Kate Petersen; Balz Frei; Tory M Hagen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-02       Impact factor: 3.619

5.  Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes.

Authors:  Biliana Marcheva; Kathryn Moynihan Ramsey; Ethan D Buhr; Yumiko Kobayashi; Hong Su; Caroline H Ko; Ganka Ivanova; Chiaki Omura; Shelley Mo; Martha H Vitaterna; James P Lopez; Louis H Philipson; Christopher A Bradfield; Seth D Crosby; Lellean JeBailey; Xiaozhong Wang; Joseph S Takahashi; Joseph Bass
Journal:  Nature       Date:  2010-07-29       Impact factor: 49.962

6.  Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2α and regulation of bile acid homeostasis.

Authors:  Sadeesh K Ramakrishnan; Matthew Taylor; Aijuan Qu; Sung-Hoon Ahn; Madathilparambil V Suresh; Krishnan Raghavendran; Frank J Gonzalez; Yatrik M Shah
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

Review 7.  Torpor induction in mammals: recent discoveries fueling new ideas.

Authors:  Richard G Melvin; Matthew T Andrews
Journal:  Trends Endocrinol Metab       Date:  2009-10-26       Impact factor: 12.015

Review 8.  Circadian clocks and metabolism.

Authors:  Biliana Marcheva; Kathryn M Ramsey; Clara B Peek; Alison Affinati; Eleonore Maury; Joseph Bass
Journal:  Handb Exp Pharmacol       Date:  2013

9.  REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis.

Authors:  Gwendal Le Martelot; Thierry Claudel; David Gatfield; Olivier Schaad; Benoît Kornmann; Giuseppe Lo Sasso; Antonio Moschetta; Ueli Schibler
Journal:  PLoS Biol       Date:  2009-09-01       Impact factor: 8.029

10.  Circadian dysregulation disrupts bile acid homeostasis.

Authors:  Ke Ma; Rui Xiao; Hsiu-Ting Tseng; Lu Shan; Loning Fu; David D Moore
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.